Zhong Ji Longevity Science Group has a Cash Ratio of 1.11. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Zhong Ji Longevity Science Group's Cash Ratio or its related term are showing as below:
HKSE:00767'
s Cash Ratio Range Over the Past 10 Years
Min: 0.44 Med: 1.68 Max: 7.02
Current: 1.11
During the past 13 years, Zhong Ji Longevity Science Group's highest Cash Ratio was 7.02. The lowest was 0.44. And the median was 1.68.
HKSE:00767's Cash Ratio is ranked better than 60.92% of 371
companies
in the Credit Services industry
Industry Median: 0.66
vs HKSE:00767: 1.11
Zhong Ji Longevity Science Group Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zhong Ji Longevity Science Group's Cash Ratio
For the Credit Services subindustry, Zhong Ji Longevity Science Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group's Cash Ratio Distribution in the Credit Services Industry
For the Credit Services industry and Financial Services sector, Zhong Ji Longevity Science Group's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's Cash Ratio falls into.
Zhong Ji Longevity Science Group Cash Ratio Calculation
The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group (HKSE:00767) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Zhong Ji Longevity Science Group Cash Ratio Related Terms
Thank you for viewing the detailed overview of Zhong Ji Longevity Science Group's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhong Ji Longevity Science Group (HKSE:00767) Business Description
Zhong Ji Longevity Science Group Ltd is an investment holding company engaged in the business of loan facilitation services business, money lending business, securities and investment business, financial and investment advisory and property investment. It is also engaged in research and development and production of longevity biological products, as well as the development of medical service business including cell and gene therapy and detection test. Its segments consist of Loan facilitation services; Money lending; Securities and other investments; Financial and investment advisory; and Property investment. It derives the majority of revenue from Money Lending segment that loan financing for interest income.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00767 has been successfully added to your 